Pharma giants gaining big in 2022

Pharma giants gaining big in 2022

International pharma giants have reported strong results for the first half of 2022, with new plans in the pipeline from many of them in this country.
Pharma groups redouble patient-centric efforts

Pharma groups redouble patient-centric efforts

Driven by 2020’s highlights, international pharma giants are planning to deliver more vital medicines and vaccines to Vietnam in 2021 to tap into local demands and enable the country to weather future crises.
Replaced regulation to hit global drugmakers

Replaced regulation to hit global drugmakers

International pharma giants like Pfizer, GSK, and Novartis are expected to be strongly hit soon by a price cut under Vietnam’s new tender rules for branded drugs, enabling local patients to receive an increase in pharmaceutical access at affordable prices.